Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: MEHMO Natural History and Biomarkers
This clinical trial MEHMO Natural History and Biomarkers is currently recruiting to study the natural history and biomarkers of conditions i…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON) [NA]
BEACON is a clinical trial in Kenya designed to bridge the treatment gap by expanding access to epilepsy care. The study is currently recrui…
-
FDA approval · 2026-02-23FDA Approved: BRIVARACETAM — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original abbreviated new drug application for a generic Brivaracetam product from Novadoz Pharmaceuticals LLC. Brivaracetam…
-
FDA approval · 2026-02-23FDA Approved: BRIVARACETAM — Original Application (Zhejiang Poly Pharm. Co., Ltd.)
FDA approved Zhejiang Poly Pharm. Co., Ltd.'s brivaracetam as a generic version, expanding access to the antiepileptic medication.
-
FDA approval · 2026-02-23FDA Approved: BRIVARACETAM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' generic version of brivaracetam through an original ANDA, expanding access to an antiseizure medicat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-02-23FDA Approved: BRIVARACETAM — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a generic injectable form of brivaracetam under an ANDA for PAI Holdings (PAI Pharma).
-
FDA approval · 2026-02-23FDA Approved: BRIVARACETAM ORAL SOLUTION — Original Application (Florida Pharmaceutical Products, LLC)
FDA approves Brivaracetam Oral Solution as an original application generic product by Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Bridging the Childhood Epilepsy Treatment Gap in Africa [NA]
Completed clinical trial evaluating approaches to bridge the childhood epilepsy treatment gap in Africa; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults [Phase 4]
Phase 4 clinical trial update evaluating the effectiveness and tolerability of levetiracetam for epilepsy in older adults has completed.
-
FDA approval · 2026-02-19FDA Approved: BRIVARACETAM — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original abbreviated new drug application for brivaracetam from Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Effect of Epilepsy and Antiepileptic Drug Therapy on Gastric Motility and Emptying With Point-Of-Care Gastric Ultrasound
This clinical trial investigates the impact of epilepsy and antiepileptic drug therapy on gastric motility and gastric emptying, assessed wi…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults?
A terminated clinical trial examined whether S100B protein levels can predict progression from a first seizure to chronic epilepsy in adults…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: LIFUS For Neurological Disorders [NA]
This clinical trial is evaluating low-intensity focused ultrasound (LIFUS) for several neurological disorders and is currently recruiting, i…
-
FDA approval · 2026-02-17FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin filed by Creekwood Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Impact of Educational Actions on the Quality Of Life of Epileptic Patients [NA]
A completed clinical trial evaluating the impact of educational actions on quality of life in epilepsy patients.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Telephone-Based Support Programs for People With Epilepsy [NA]
A clinical trial update announcing a recruiting study on telephone-based support programs for people with epilepsy.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Mindfulness Meditation for Epilepsy [NA]
A Rennes University Hospital-sponsored clinical trial evaluating mindfulness meditation for epilepsy has completed.
-
EMA approval · 2026-02-16EMA Authorised: Pregabalin Zentiva (pregabalin) — Zentiva, k.s.
EMA authorised a generic pregabalin product, Pregabalin Zentiva, for anxiety disorders and epilepsy.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Short Versus Long-term Levetiracetam in Brain Tumors [Phase 3]
Phase 3 trial comparing short-term versus long-term use of levetiracetam in patients with brain tumors and seizures; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli
This update notes the completion of a clinical trial evaluating detection of paroxysmal events in epilepsy using computer vision and machine…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)
A University of South Florida study sponsored by Neuro Event Labs Inc. evaluating detection of paroxysmal events in epilepsy using computer …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Localizing Epileptic Networks Using MRI and iEEG [EARLY_Phase 1]
Clinical trial update for an early-phase 1 study from the University of Pennsylvania using MRI and intracranial EEG to localize epileptic ne…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: 5-SENSE Score Validation Study
A clinical trial update indicates that the 5-SENSE Score validation study for epilepsy is currently enrolling by invitation at Duke Universi…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Pediatric Epilepsy [NA]
A pediatric epilepsy trial sponsored by the University of Texas Southwestern Medical Center is not yet recruiting.
-
FDA approval · 2026-02-12FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin by Ascend Laboratories, LLC, updating regulatory approval for this generic product.